The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Forecasted Market Size Figures For The Biological Polymerase Chain Reaction (PCR) Technology Market In 2026 And 2030?
The market for biological polymerase chain reaction (PCR) technology has expanded rapidly in recent years. This market is projected to increase from $16.62 billion in 2025 to $18.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. Historically, this growth has been influenced by factors such as the wider adoption of molecular diagnostics, the growing application of PCR in infectious disease testing, an increase in genomic research activities, a heightened need for accurate nucleic acid amplification, and enhancements in thermal cycler technologies.
The market size for biological polymerase chain reaction (pcr) technology is predicted to show robust expansion over the next few years. It is set to expand to $26.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.9%. This anticipated growth during the forecast period can be credited to the increasing embrace of point-of-care pcr systems, the growing application of pcr in oncology and genetic testing, the advancement of personalized medicine, increasing financial commitments to laboratory automation, and the rising need for rapid diagnostic solutions. Significant trends identified for the forecast period include the wider adoption of real-time and digital pcr techniques, an escalating demand for high-sensitivity molecular diagnostics, the increasing incorporation of pcr data analysis software, the broadening of multiplex and high-throughput pcr applications, and a reinforced emphasis on workflow automation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27223&type=smp
What Primary Factors Are Fueling The Expansion Of The Biological Polymerase Chain Reaction (PCR) Technology Market?
The increasing occurrence of infectious diseases is anticipated to drive the expansion of the biological polymerase chain reaction (PCR) technology market moving ahead. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites, referring to disorders brought about by these organisms. The growing prevalence of infectious diseases is fueled by a rise in global travel, which enables quicker and broader dissemination of pathogens across various areas. Biological polymerase chain reaction (PCR) technology assists in combating infectious diseases through its capacity for swift and precise pathogen detection, thereby facilitating early diagnosis, prompt treatment, and efficient outbreak management. As an illustration, in December 2024, the World Health Organization, an intergovernmental agency headquartered in Switzerland, reported that in 2023, malaria, a significant infectious disease, led to an estimated 263 million cases worldwide. This marked an increase of approximately 252 million from 2022, with a case incidence of 60.4 per 1,000 population at risk, rising from 58.6 in 2022. Additionally, there were 597,000 deaths, and 94 percent of cases along with 95 percent of deaths occurred in the WHO African Region. Consequently, the increasing occurrence of infectious diseases is propelling the expansion of the biological polymerase chain reaction (PCR) technology market.
How Is The Biological Polymerase Chain Reaction (PCR) Technology Market Structured Across Different Market Segments?
The biological polymerase chain reaction (pcr) technology market covered in this report is segmented –
1) By Product Type: Reagents, Consumables, Software And Services
2) By Technique: Real-Time Polymerase Chain Reaction (PCR), Conventional Polymerase Chain Reaction (PCR), Digital Polymerase Chain Reaction (PCR), Reverse Transcription Polymerase Chain Reaction (PCR), Hot-Start Polymerase Chain Reaction (PCR), Multiplex Polymerase Chain Reaction (PCR), Other Polymerase Chain Reaction (PCR) Techniques
3) By Application: Diagnostic Applications, Genotyping, Nucleic Acid Detection, Gene Expression Analysis, Nucleic Acid Synthesis, Genetic Sequencing, Environmental Applications, Standard Validation Or Verification, Other Applications
4) By End User: Hospital Laboratories, Diagnostic Laboratories, Academic And Government Organizations, Pharma-Biotech Companies, Other End Users
Subsegments:
1) By Reagents: DNA Polymerase, DNTPs, Primers And Probes, Buffers And Master Mixes, Enzymes, Nucleic Acid Templates, Additives And Enhancers
2) By Consumables: PCR Tubes, PCR Plates, Sealing Films And Mats, Microplates, Reaction Vessels, Pipette Tips, PCR Strips
3) By Software And Services: PCR Data Analysis Software, Real-Time PCR Analysis Software, Cloud-Based Data Storage Solutions, PCR Workflow Management Tools, Technical Support Services, Calibration And Maintenance Services, Training And Consultation Services
What Trends Are Influencing The Biological Polymerase Chain Reaction (PCR) Technology Market Outlook?
Major companies engaged in the biological polymerase chain reaction (PCR) technology market are concentrating on technological advancements, such as digital PCR assay kits, to facilitate precise and efficient quantification of DNA and RNA for biopharma research, cell and gene therapies, and food safety. Digital PCR assay kits refer to laboratory reagent kits utilized for highly sensitive and precise DNA or RNA quantification through digital PCR technology. For instance, in November 2023, QIAGEN, a Netherlands-based provider of molecular biology solutions, launched its QIAcuity Digital PCR Kits and an updated QIAcuity software to extend their applications in biopharma and food-safety testing. These kits use optimized reagents and consumables to partition nucleic acid samples into thousands of nanoliter-scale reactions, allowing for sensitive detection and quantification of rare variants or pathogens. The updated software offers automated analysis, workflow guidance, and data visualization for easier interpretation. Key features include high sensitivity, a broad dynamic range, multiplexing capability, and user-friendly operation. Applications span gene expression analysis, mutation detection, microbial testing, and quality control, providing increased accuracy, reduced hands-on time, and reliable low-copy detection across research and regulatory settings.
Who Are The Leading Firms Participating In The Biological Polymerase Chain Reaction (PCR) Technology Market?
Major companies operating in the biological polymerase chain reaction (pcr) technology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Cepheid Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena GmbH+Co. KG, New England Biolabs Inc., Enzo Biochem Inc., LGC Biosearch Technologies Inc., Bioline Reagents Ltd., Illumina Inc., Abbott Laboratories
Access The Complete Biological Polymerase Chain Reaction (PCR) Technology Market Report:
Which Region Stands As The Largest Contributor To The Biological Polymerase Chain Reaction (PCR) Technology Market?
North America was the largest region in the biological polymerase chain reaction (PCR) technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological polymerase chain reaction (pcr) technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Biological Polymerase Chain Reaction (PCR) Technology Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=27223&type=smp
Browse Through More Reports Similar to the Global Biological Polymerase Chain Reaction (PCR) Technology Market 2026, By The Business Research Company
Hydrocolloids Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydrocolloids-global-market-report
Hydrocortisone Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydrocortisone-global-market-report
Food Hydrocolloids Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/food-hydrocolloids-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model